Transcripts Avalo Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-24 EDT			5-day change	1st Jan Change
19.27 ^USD	-2.82%		-3.41%	+6.11%

08-19	Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing	MT
08-06	Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

24-12-05	Avalo Therapeutics, Inc. Presents at Piper Sandler 36th Annual Healthcare Conference, Dec-05-2024 11:00 AM
24-11-18	Avalo Therapeutics, Inc. Presents at Stifel 2024 Healthcare Conference, Nov-18-2024 03:35 PM
24-03-28	Avalo Therapeutics, Inc., AlmataBio, Inc. - M&A Call
19-11-14	Cerecor Inc. Provides Revenue Guidance for the Year 2019	CI
19-08-08	Cerecor Inc. Reaffirms Earnings Guidance for the Full Year 2019; Announces Impairment Charges for the Second Quarter Ended June 30, 2019	CI
19-05-09	Cerecor Inc. Provides Revenue Guidance for the Full Year 2019	CI
19-03-18	Cerecor Inc. Provides Earnings Guidance for the Full Year of 2019	CI